Nicholas J. Thomas

1.8k total citations · 1 hit paper
35 papers, 851 citations indexed

About

Nicholas J. Thomas is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Nicholas J. Thomas has authored 35 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Genetics and 11 papers in Surgery. Recurrent topics in Nicholas J. Thomas's work include Diabetes and associated disorders (12 papers), Diabetes Management and Research (10 papers) and Pancreatic function and diabetes (9 papers). Nicholas J. Thomas is often cited by papers focused on Diabetes and associated disorders (12 papers), Diabetes Management and Research (10 papers) and Pancreatic function and diabetes (9 papers). Nicholas J. Thomas collaborates with scholars based in United Kingdom, United States and Italy. Nicholas J. Thomas's co-authors include Andrew T. Hattersley, Michael N. Weedon, Richard A. Oram, Beverley M. Shields, Samuel E. Jones, Angus G. Jones, John Dennis, Andrew McGovern, Bilal A. Mateen and Sebastian J. Vollmer and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Nicholas J. Thomas

34 papers receiving 836 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank

2017 280 citations Nicholas J. Thomas, Samuel E. Jones et al. The Lancet Diabetes & Endocrinology profile →

Peers

Nicholas J. Thomas

EDM

GENET

SURGE

EPIDE

Lenita Zajdenverg Brazil

Sze May Ng United Kingdom

Joel Zonszein United States

Najmul Islam Pakistan

G Giuffrida Italy

Lorenzo Lupo Italy

William Koltun United States

Kristian Lynch Sweden

Laura Mazoni Italy

Bart G.P. Koot Netherlands

Lenita Zajdenverg Brazil

Nicholas J. Thomas

397 ×0.9

EDM

268 ×0.6

GENET

265 ×0.8

SURGE

162 ×1.4

60 ×0.6

EPIDE

Citations per year, relative to Nicholas J. Thomas Nicholas J. Thomas (= 1×) peers Lenita Zajdenverg

Countries citing papers authored by Nicholas J. Thomas

Since Specialization

Citations

This map shows the geographic impact of Nicholas J. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas J. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas J. Thomas more than expected).

Fields of papers citing papers by Nicholas J. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas J. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas J. Thomas. The network helps show where Nicholas J. Thomas may publish in the future.

Co-authorship network of co-authors of Nicholas J. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas J. Thomas. A scholar is included among the top collaborators of Nicholas J. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas J. Thomas. Nicholas J. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferrat, Lauric, Nicholas J. Thomas, Diane K. Wherrett, et al.. (2025). Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study. Diabetes Care. 48(9). 1571–1580. 1 indexed citations

Appiah, Bernard, Calvin Moorley, Nicholas J. Thomas, et al.. (2025). Public awareness of stroke risk factors in high-income countries: A systematic review. Journal of Stroke and Cerebrovascular Diseases. 34(12). 108501–108501.

Young, Katherine, Nicholas J. Thomas, Bilal A. Mateen, et al.. (2024). Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study. BMJ Open. 14(1). e078135–e078135. 6 indexed citations

Thomas, Nicholas J., Robert Challen, Angus G. Jones, et al.. (2024). Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach. Diabetologia. 67(9). 1817–1827. 9 indexed citations

Young, Katherine, Andrew McGovern, Inês Barroso, et al.. (2022). The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis. Diabetologia. 66(2). 300–309. 4 indexed citations

Thomas, Nicholas J., Andrew McGovern, Katherine Young, et al.. (2022). Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches. Journal of Clinical Epidemiology. 153. 34–44. 14 indexed citations

Thomas, Nicholas J., Helen C. Walkey, Shivani Misra, et al.. (2022). The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes. Diabetologia. 66(2). 310–320. 15 indexed citations

Mateen, Bilal A., John Dennis, Andrew J. Duncan, et al.. (2021). Hospital bed capacity and usage across secondary healthcare providers in England during the first wave of the COVID-19 pandemic: a descriptive analysis. BMJ Open. 11(1). e042945–e042945. 26 indexed citations

McGovern, Andrew, Nicholas J. Thomas, Sebastian J. Vollmer, et al.. (2021). The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation. Diabetologia. 64(5). 1184–1186. 14 indexed citations

10.

Joshi, Manisha, et al.. (2021). “They are not satisfied until they see our blood”: Syndemic HIV risks for trans women in urban Haiti. International Journal of Mental Health. 50(4). 337–367. 1 indexed citations

11.

Evans, Benjamin D., Piotr Słowiński, Andrew T. Hattersley, et al.. (2021). Estimating disease prevalence in large datasets using genetic risk scores. Nature Communications. 12(1). 6441–6441. 5 indexed citations

12.

Thomas, Nicholas J., John Dennis, Seth A. Sharp, et al.. (2021). DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life. Diabetologia. 64(10). 2258–2265. 17 indexed citations

13.

Májovský, Martin, André Grotenhuis, Nikolaos Foroglou, et al.. (2021). What is the current clinical practice in pituitary adenoma surgery in Europe? European Pituitary Adenoma Surgery Survey (EU-PASS) results—technical part. Neurosurgical Review. 45(1). 831–841. 9 indexed citations

14.

Dennis, John, Bilal A. Mateen, Raphael Sonabend, et al.. (2020). Type 2 Diabetes and COVID-19–Related Mortality in the Critical Care Setting: A National Cohort Study in England, March–July 2020. Diabetes Care. 44(1). 50–57. 120 indexed citations

15.

Sharp, Seth A., Nicholas J. Thomas, Jamie Harrison, et al.. (2020). IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank. Kidney International Reports. 5(10). 1643–1650. 19 indexed citations

16.

Arya, Ved Bhushan, Dunia Ismail, Ritika R. Kapoor, et al.. (2018). Growth Hormone (GH) Secreting Pituitary Adenomas in Paediatric Practice: 5 Cases Over 20 Years in a Single Tertiary NeuroEndocrine Centre. 1 indexed citations

17.

Zhang, Mengxi, et al.. (2018). A Meta-analysis of the Association Between Needle Exchange Programs and HIV Seroconversion Among Injection Drug Users. Cureus. 10(9). e3328–e3328. 7 indexed citations

18.

Thomas, Nicholas J., Samuel E. Jones, Michael N. Weedon, et al.. (2017). Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. The Lancet Diabetes & Endocrinology. 6(2). 122–129. 280 indexed citations breakdown →

19.

Vedovato, Natascia, Kashyap Patel, Nicholas J. Thomas, et al.. (2016). Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes. Diabetologia. 59(6). 1162–1166. 61 indexed citations

20.

Guha, Nishan, et al.. (2009). IGF-I Abuse in Sport. Current Drug Abuse Reviews. 2(3). 263–272. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact